Does SPIRONOLACTONE Cause Pulmonary mass? 105 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Pulmonary mass have been filed in association with SPIRONOLACTONE (spironolactone). This represents 0.5% of all adverse event reports for SPIRONOLACTONE.
105
Reports of Pulmonary mass with SPIRONOLACTONE
0.5%
of all SPIRONOLACTONE reports
0
Deaths
88
Hospitalizations
How Dangerous Is Pulmonary mass From SPIRONOLACTONE?
Of the 105 reports, 88 (83.8%) required hospitalization.
Is Pulmonary mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SPIRONOLACTONE. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does SPIRONOLACTONE Cause?
Acute kidney injury (3,273)
Hyperkalaemia (2,518)
Hypotension (1,583)
Dyspnoea (1,468)
Drug ineffective (1,379)
Hyponatraemia (1,166)
Dizziness (991)
Fatigue (990)
Fall (947)
Off label use (899)
What Other Drugs Cause Pulmonary mass?
ADALIMUMAB (1,299)
METHOTREXATE (1,153)
PREDNISONE (755)
ALBUTEROL (736)
ETANERCEPT (665)
TIOTROPIUM (624)
RITUXIMAB (531)
BUDESONIDE\FORMOTEROL (464)
MEPOLIZUMAB (450)
LEFLUNOMIDE (430)
Which SPIRONOLACTONE Alternatives Have Lower Pulmonary mass Risk?
SPIRONOLACTONE vs SPRYCEL
SPIRONOLACTONE vs STALEVO
SPIRONOLACTONE vs STANNOUS FLUORIDE
SPIRONOLACTONE vs STANOZOLOL
SPIRONOLACTONE vs STAVUDINE